# HSIC — Henry Schein Inc · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** HSIC  
**Sources:** 23  
**Published:** 2026-10-03  
**Canonical:** https://app.k3vl4r.com/research/deep-research-hsic-henry-schein-inc-catalysts-narrative-risks-5919

---

## Current snapshot (as of early October 2026)

Henry Schein (HSIC, Nasdaq, S&P 500) is a FORTUNE 500 healthcare distributor serving office-based dental and medical practitioners, laboratories, and clinics worldwide [[14]](https://finance.yahoo.com/quote/HSIC/), [[17]](https://www.stocktitan.net/overview/HSIC/). As of October 2, 2026, the stock closed at ~$84.88 with a market cap of ~$9.46B [[14]](https://finance.yahoo.com/quote/HSIC/), [[16]](https://finance.yahoo.com/quote/HSIC/news/). Key metrics: trailing P/E ~24.75, forward P/E ~15.01, EPS (TTM) ~$3.43, no dividend, ~6.85% short interest (~8.3 days to cover), and ~96.6% institutional ownership [[15]](https://www.marketbeat.com/stocks/NASDAQ/HSIC/), [[19]](https://stockanalysis.com/stocks/hsic/). The 52-week range is $61.95–$92.18 [[14]](https://finance.yahoo.com/quote/HSIC/).

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-hsic-henry-schein-inc-catalysts-narrative-risks-5919 (free to sign up)._
